TROAP and adrenal cortex carcinoma: Upregulated TROAP predicts the poor OS and DFS in patients with adrenocortical carcinoma, kidney renal clear cell carcinoma, pancreatic adenocarcinoma, skin cutaneous melanoma and HCC.